Does Lemonade’s Growth Signal Profits Ahead?
Lemonade (NYSE: LMND) has always had an audacious idea.
The insurer would rebuild insurance using artificial intelligence and behavioral economics to streamline buying policies and filing claims, replace brokers with bots, and pay claims in seconds. For years, non-believers dismissed it as a cash-burning app dressed up as an insurer.
This year, though, the company is starting to post numbers that answer these critics. The stock, however, is still not convinced.
But a fresh quarterly report in early November and an Investor Day are both on the calendar. And management has circled the fourth quarter of 2026 for delivering its first quarter of positive adjusted EBITDA.
For investors, the next few months could be a proof-of-concept moment.
Growth Accelerates Across Key Metrics
Second-quarter results, announced July 29, helped set the scene. Revenue soared 79.4% to $294.4 million, edging past the Wall Street consensus of $291 million. The company’s loss of $43 million, or 56 cents per share, matched forecasts exactly.
The more important number was in-force premium, the total annualized value of policies on the books. It reached $1.43 billion, up 32.4% from a year earlier, the 11th consecutive quarter of accelerating growth. Customer count rose 23% to 3.3 million, and the company added about 166,000 new customers in the quarter, about 12% more than in the prior year’s three months.
That momentum built on a solid 2025. Full-year revenue last year climbed 40% to $737.9 million, while the net loss narrowed to $165.5 million from $202.2 million.
Underwriting Performance Continues to Improve
Growth on its own doesn’t help insurers if they write bad policies. Lemonade made progress here also. The gross loss ratio, the share of premiums paid out in claims, came in at 60% in the second quarter. Just over a year ago, that figure was running at 78%.
Its AI-heavy claims operation is also paying off. The cost of handling claims fell to a record 5% of premiums, compared with an industry average of roughly 9%. Gross profit rose 76% to a record $113 million, representing a gross margin of 38%.
Losses are also shrinking. The adjusted EBITDA loss improved to $19 million from $41 million and adjusted free cash flow was positive for a fifth straight quarter at $19 million.
Management raised its full-year outlook to roughly 65% revenue growth and 33% in-force premium growth.
Car Insurance Drives Expansion
The positive thesis rests on Lemonade becoming a multi-product insurer, not a renters-and-pets niche player, and car insurance is the key.
Lemonade Car grew nearly 60% year-over-year in the second quarter, and an Aug. 26 launch in Florida brought it to states representing nearly 50% of the U.S. car insurance market. In January, the company launched insurance that cut rates for miles driven on Tesla (NASDAQ: TSLA) Full Self-Driving by 50%, and it has since taken that product to Indiana, Colorado, and Tennessee.
More recently, the company has announced a slew of expansions, with pet insurance launched in Kentucky, and renters’ coverage in Kansas and Alaska, part of a pace of 14 new state-product launches in about 100 days.
Profitability Remains the Biggest Risk
The challenge is Lemonade still loses money. Its trailing 12-month loss is $1.83 per share.
Wall Street expects the loss to narrow to $1.06 per share next year, which means profits probably remain a distant target. The stock also trades at about 4.8 times sales and almost 6.5 times book value, which is rather rich for an insurer.
Expectations have also been high. The stock fell 20% after the July 29 report because the outlook, while raised, did not provide the bigger catalyst investors had already priced in.
Competition is also intensifying. Although aggressive, Lemonade remains a small player next to car insurance giants such as Progressive (NYSE: PGR), Allstate (NYSE: ALL), and Berkshire Hathaway's (NYSE: BRK.B) GEICO. It also faces digital challenger Root (NASDAQ: ROOT) and pet specialist Trupanion (NASDAQ: TRUP).
Traders are clearly betting against the stock, with roughly 16% of the float sold short.
Analysts Remain Divided on Lemonade
Analysts are split on the stock, giving it a consensus Hold rating. With nine analysts tracking the stock, four have given the company a Buy rating, four have assigned Hold, and one suggests Sell.
The 12-month average price target is $63.50, implying about 36% upside, within a range of $92 per share at the high end and a low of $44.
Shares have also taken a hit this year. The stock is down more than 34% since the start of the year and has fallen even more compared with its 52-week high of $99.90 in late January.
The Sell-Off Could Create an Opportunity
The curious reality is that Lemonade today is a better business than it was when the stock sat near $100. Growth is accelerating, underwriting has improved, and positive EBITDA is within reach.
The 2026 sell-off has reset expectations, and that reset could bring some appeal to investors looking for beaten-down growth stocks.
But profitability remains a central issue. The next earnings report and the company’s Nov. 17 Investor Day could be determinative if the company can confirm its path to positive results.
Where Should You Invest $1,000 Right Now?
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
